Atrium Therapeutics, Inc. (RNA)
7.84
-0.30
(-3.69%)
USD |
NASDAQ |
Oct 02, 16:00
7.98
+0.14
(+1.79%)
Pre-Market: 20:00
Atrium Therapeutics EPS Diluted (Quarterly) : -1.18 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.18 |
| March 31, 2026 | -0.9724 |
| December 31, 2025 | -1.702 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.7529 |
| March 31, 2025 | -0.4355 |
| December 31, 2024 | -0.6726 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -0.35 |
| Exicure, Inc. | -0.1759 |
| Century Therapeutics, Inc. | -0.1679 |
| Absci Corp. | -0.2109 |
| Celularity, Inc. | 0.0223 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.19M |
| Revenue (Quarterly) | 3.004M |
| Total Expenses (Quarterly) | 23.19M |
| Enterprise Value | -128.42M |
| Gross Profit Margin (Quarterly) | 88.58% |
| Profit Margin (Quarterly) | -672.0% |
| Earnings Yield | -58.77% |
| Normalized Earnings Yield | -58.77 |